Front Desk: 469-391-0070
Paclitaxel Chemotherapy: Uses, Dosage, and Side Effects Explained
Summary of Key Points
Paclitaxel is a chemotherapy drug used to treat various cancers, including breast, ovarian, and lung cancer. It works by stopping the growth of cancer cells. Paclitaxel is typically given through an intravenous (IV) infusion by a healthcare professional. Like all chemotherapy medications, it can cause side effects, so it’s important to discuss any concerns with your doctor. Our telemedicine providers are available to help manage your treatment and address any questions you may have.
Names of Medication
US Brand Name: Taxol
Generic Name: Paclitaxel
The generic name refers to the drug’s chemical composition, while the brand name is the marketed version. In this article, we will primarily use the generic name, Paclitaxel, in parentheses.
Pharmacologic Category
Category: Antineoplastic Agent, Mitotic Inhibitor
Paclitaxel belongs to a class of medications known as antineoplastic agents, which are used to treat cancer. Other drugs in this category include docetaxel and cabazitaxel. These chemotherapy agents work by preventing cancer cells from dividing and multiplying.
Paclitaxel Dosing
Paclitaxel is used to treat several types of cancer in adults, with dosing varying based on the specific cancer being treated. Always consult your doctor before making any changes to your dose. Our telemedicine providers are available to guide you through your treatment plan.
Paclitaxel for Breast Cancer
Recommended Dose: 175 mg/m² administered as an intravenous (IV) infusion over 3 hours every 3 weeks.
Paclitaxel for Ovarian Cancer
Recommended Dose: 135 mg/m² administered as an IV infusion over 24 hours, followed by cisplatin every 3 weeks.
Paclitaxel for Non-Small Cell Lung Cancer
Recommended Dose: 135 mg/m² administered as an IV infusion over 24 hours, followed by cisplatin every 3 weeks.
Paclitaxel for Pancreatic Cancer
Recommended Dose: 125 mg/m² administered as an IV infusion over 30 minutes on Days 1, 8, and 15 of each 28-day cycle.
Paclitaxel for Kaposi’s Sarcoma
Recommended Dose: 100 mg/m² administered as an IV infusion over 3 hours every 2 weeks.
Paclitaxel for Esophageal Cancer
Recommended Dose: 175 mg/m² administered as an IV infusion over 3 hours every 3 weeks.
Paclitaxel for Bladder Cancer
Recommended Dose: 175 mg/m² administered as an IV infusion over 3 hours every 3 weeks.
Paclitaxel for Head and Neck Cancer
Recommended Dose: 175 mg/m² administered as an IV infusion over 3 hours every 3 weeks.
Paclitaxel for Small Cell Lung Cancer
Recommended Dose: 135 mg/m² administered as an IV infusion over 24 hours, followed by cisplatin every 3 weeks.
Paclitaxel for Uterine Cancer
Recommended Dose: 175 mg/m² administered as an IV infusion over 3 hours every 3 weeks.
Dosage Forms and Strengths
Injection, solution: 6 mg/mL in 5 mL, 16.7 mL, 25 mL, and 50 mL vials
Paclitaxel Administration Instructions
Paclitaxel is administered by a healthcare professional through an intravenous (IV) infusion. The duration of the infusion can range from 3 to 24 hours, depending on the dose and the type of cancer being treated. It’s essential to follow your doctor’s instructions closely. In some cases, pre-medications may be required to prevent allergic reactions. If you have any questions or concerns, our telemedicine providers are here to support you.
Contraindications for Paclitaxel
A contraindication is a specific condition where a medication should not be used because it may cause harm. Below are the contraindications for Paclitaxel:
- Severe hypersensitivity to Paclitaxel or its ingredients: If you’ve experienced an allergic reaction to Paclitaxel or any of its components, you should avoid this medication. Allergic reactions can be serious and may include symptoms such as difficulty breathing, swelling, or a severe rash.
- Neutropenia (low white blood cell count): Paclitaxel can further lower white blood cell counts, increasing the risk of serious infections.
- Severe liver impairment: The liver is responsible for processing Paclitaxel. If liver function is impaired, the drug may accumulate in the body, leading to toxic side effects.
- Pregnancy: Paclitaxel can harm an unborn baby. It is contraindicated during pregnancy unless the potential benefits outweigh the risks, as determined by your healthcare provider.
Drug-to-Drug Interactions with Paclitaxel
Paclitaxel may interact with other medications, which can increase the risk of side effects or reduce the effectiveness of either drug. Be sure to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Some medications that may interact with Paclitaxel include:
- Carboplatin (Paraplatin): Using Carboplatin with Paclitaxel may increase the risk of bone marrow suppression, leading to low blood cell counts.
- Cisplatin (Platinol): When combined with Paclitaxel, Cisplatin can raise the risk of kidney and nerve damage.
- Ketoconazole (Nizoral): This antifungal medication can increase Paclitaxel levels in the body, potentially leading to more severe side effects.
- Rifampin (Rifadin): Rifampin may reduce the effectiveness of Paclitaxel by speeding up its breakdown in the body.
- Phenytoin (Dilantin): This anti-seizure medication can decrease the effectiveness of Paclitaxel by increasing its metabolism.
Paclitaxel in Pregnancy
Is it safe to take Paclitaxel when pregnant?
Paclitaxel is generally not considered safe during pregnancy. It is classified as a Category D medication, meaning it carries potential risks to the developing baby, including birth defects or miscarriage. If you are pregnant or planning to become pregnant, it is crucial to discuss this with your healthcare provider. In certain situations, the benefits of Paclitaxel chemotherapy may outweigh the risks, but this decision should be made carefully in consultation with your doctor. If you are currently taking Paclitaxel and discover you are pregnant, contact your healthcare provider immediately for guidance.
Paclitaxel while Breastfeeding
Is it safe to take Paclitaxel while breastfeeding?
Paclitaxel is not recommended for use while breastfeeding, as it may pass into breast milk and potentially harm a nursing infant. If you are breastfeeding or planning to breastfeed, it is important to discuss alternative treatment options with your healthcare provider. You may need to temporarily stop breastfeeding while undergoing Paclitaxel chemotherapy.
Estimated Cost of Paclitaxel
The cost of Paclitaxel can vary depending on the pharmacy and location. Without insurance, a 30-day supply using a GoodRx coupon is estimated to range between $150 and $300. Prices may fluctuate, so it’s a good idea to check with your local pharmacy or use a discount service like GoodRx for the most up-to-date pricing information.
Possible Alternatives to Paclitaxel
Depending on the type of cancer, there may be alternative treatments or therapies available. It is essential to consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore these options further.
Breast Cancer
For breast cancer, alternatives to Paclitaxel may include other chemotherapy drugs such as Doxorubicin (Adriamycin) or targeted therapies like Trastuzumab (Herceptin). Hormonal therapies, such as Tamoxifen, may also be considered for certain types of breast cancer.
Ovarian Cancer
Common alternatives for ovarian cancer include Carboplatin and Cisplatin. In some cases, targeted therapies like Bevacizumab (Avastin) may also be used.
Non-Small Cell Lung Cancer
For non-small cell lung cancer, alternatives may include Pemetrexed (Alimta) or targeted therapies such as Erlotinib (Tarceva), particularly for patients with specific genetic mutations.
Pancreatic Cancer
Gemcitabine (Gemzar) or FOLFIRINOX, a combination of chemotherapy drugs, may be used as alternatives to Paclitaxel for treating pancreatic cancer.
Kaposi’s Sarcoma
Liposomal Doxorubicin (Doxil) is often used as an alternative to Paclitaxel for treating Kaposi’s sarcoma.
Esophageal Cancer
For esophageal cancer, Cisplatin and 5-fluorouracil (5-FU) are common alternatives. Radiation therapy may also be considered as part of the treatment plan.
Bladder Cancer
Alternatives for bladder cancer include Cisplatin-based chemotherapy or immunotherapy with drugs like Atezolizumab (Tecentriq).
Head and Neck Cancer
Cisplatin or Cetuximab (Erbitux) may be used as alternatives for head and neck cancer, often in combination with radiation therapy.
Small Cell Lung Cancer
Etoposide and Cisplatin are common alternatives to Paclitaxel for treating small cell lung cancer.
Uterine Cancer
For uterine cancer, Doxorubicin or Carboplatin may be used as alternatives. Hormonal therapies, such as Medroxyprogesterone (Provera), may also be considered for certain types of uterine cancer.
Recent Updates on Paclitaxel Research
Recent research has focused on improving the delivery of Paclitaxel to reduce side effects and enhance its effectiveness. One promising area of study involves nanoparticle formulations of Paclitaxel, which may allow for more targeted delivery to cancer cells, minimizing damage to healthy tissues. Researchers are also exploring the combination of Paclitaxel with immunotherapy drugs to strengthen the body’s immune response against cancer cells.
Ongoing clinical trials are investigating Paclitaxel in combination with newer targeted therapies and personalized medicine approaches, aiming to tailor treatment based on the genetic makeup of the tumor. These advancements could lead to more effective and less toxic treatment options in the future.
If you are interested in learning more about the latest research or clinical trials involving Paclitaxel, speak with your healthcare provider. You can also schedule a telemedicine appointment with one of our providers to explore whether these new treatments may be suitable for you.
